AbbVie presents an in-depth look at our research and development pipeline for investors on June 3, 2016. This site provides information from the event, including complete presentation materials and additional resources on Oncology, Immunology, Neuroscience and Virology.
AbbVie R&D Day 2016
AbbVie’s late-stage pipeline has the potential to deliver more than 20 new medicines or indications by 2020. For more details on our growth strategy view the full AbbVie R&D Day presentation and webcast, agenda, videos, speaker bios and more.
1. Choose a social login method 2. Grant ISEBOX permission